| Biocon Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532523 |
NSE Symbol : BIOCON |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE376G01013 |
Div & Yield% : 0.11 |
EPS(TTM) : 0.60 |
|
Book Value(₹) : 119.54 |
Market Cap(₹Cr) : 52,515.93 |
Face Value(₹) : 5.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 583.30 | 537.10 | 643.80 | 562.80 | 525.40 | 510.60 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 583.30 | 537.10 | 643.80 | 562.80 | 525.40 | 510.60 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 133.80 | 61.30 | 62.70 | 671.70 | 73.50 | 41.90 |
| Total Income | 717.10 | 598.40 | 706.50 | 1,234.50 | 598.90 | 552.50 |
| Total Expenditure | 530.40 | 516.50 | 581.80 | 531.50 | 487.80 | 465.70 |
| PBIDT | 186.70 | 81.90 | 124.70 | 703.00 | 111.10 | 86.80 |
| Interest | 67.20 | 56.20 | 56.70 | 65.30 | 59.70 | 55.20 |
| PBDT | 119.50 | 25.70 | 68.00 | 637.70 | 51.40 | 31.60 |
| Depreciation | 33.80 | 33.30 | 33.00 | 33.80 | 30.50 | 30.50 |
| Tax | 3.20 | 1.10 | 26.50 | 8.40 | 13.20 | 2.40 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 11.60 | -0.40 | -12.70 | 11.50 | 4.50 | -2.20 |
| Reported Profit After Tax | 70.90 | -8.30 | 21.20 | 584.00 | 3.20 | 0.90 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 587.60 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 70.90 | -8.30 | 21.20 | -3.60 | 3.20 | 0.90 |
| EPS (Unit Curr.) | 0.55 | -0.07 | 0.18 | 4.88 | 0.03 | 0.01 |
| EPS (Adj) (Unit Curr.) | 0.55 | -0.07 | 0.18 | 4.88 | 0.03 | 0.01 |
| Calculated EPS (Unit Curr.) | 0.53 | -0.06 | 0.18 | 4.86 | 0.03 | 0.01 |
| Calculated EPS (Adj) (Unit Curr.) | 0.53 | -0.06 | 0.18 | 4.86 | 0.03 | 0.01 |
| Calculated EPS (Ann.) (Unit Curr.) | 2.12 | -0.25 | 0.71 | 19.46 | 0.11 | 0.03 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 2.12 | -0.25 | 0.71 | 19.46 | 0.11 | 0.03 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 668.50 | 668.50 | 600.30 | 600.30 | 600.30 | 600.30 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 32.01 | 15.25 | 19.37 | 124.91 | 21.15 | 17.00 |
| PBDTM(%) | 20.49 | 4.78 | 10.56 | 113.31 | 9.78 | 6.19 |
| PATM(%) | 12.15 | -1.55 | 3.29 | 103.77 | 0.61 | 0.18 |